CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America
Jacobson, Caron A
Shah, Parth S.
In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL). INDICE: The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic LeukemiaChimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell LymphomaChimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic LeukemiaChimeric Antigen Receptor T Cells in Multiple MyelomaChimeric Antigen Receptor T Cells in Hodgkin and T-Cell LymphomasChimeric Antigen Receptor T Cells in Acute Myeloid LeukemiaChimeric Antigen Receptor T-Cell Therapy for Solid TumorsEarly and Late Toxicities of Chimeric Antigen Receptor T-CellsMechanisms of Resistance to Chimeric Antigen Receptor T Cell TherapyThe Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific AntibodiesThe Future of Chimeric Antigen Receptor T Cell Therapy
- ISBN: 978-0-443-18300-3
- Editorial: Elsevier
- Encuadernacion: Cartoné
- Páginas: 240
- Fecha Publicación: 13/10/2023
- Nº Volúmenes: 1
- Idioma: Inglés